Watch CYCN. Know when insiders buy.
One email the day a filing lands. Free.
CYCN
Korsana Biosciences, Inc.
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $1.9M −12.6%NET INCOME −$6.7MNET CASH —52W —SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose CYCN in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
J. Wood Capital Advisors LLC and 1 related0.1%
FMR LLC and 1 related6.9%
GENERAL ATLANTIC, L.P. and 16 related6.8%
Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.6.1%
Venrock Healthcare Capital Partners III, L.P. and 8 related9.9%
“The Reporting Persons purchased the aforementioned securities for investment purposes with the aim of increasing the value of their investments and the Issuer. Subject to applicable legal requirements, one or more of the Reporting Persons may purchase additional securities of the Issuer from time to…”
Fairmount Funds Management LLC and 4 related20.0%
“The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company's aggregate outstanding shares as of September 8, 2026. The Reporting Persons' securities include (a) 2,691 shares of Common Stock issuable upon the exercise of options held directly by Mr. Kiselak that are curr…”
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.